Revised Ph. Eur. Chapter on Foreign Matter
Recommendation

Thursday, 29 October 2026 9 .00 - 17.15 h
AI/ML-based Methods for Optimizing Pharmaceutical Research Processes
Following the draft chapter 2.8.2 Foreign Matter in herbal drugs (Pharmeuropa 33.3) the final version has been published in the European Pharmacopoeia (Ph. Eur.) 11.1. The supplement is now available and will become applicable as of 1 April 2023.
In particular, the requirements for other foreign elements like moulds, insects and other animal contamination have been further specified:
Foreign matter is material consisting of any or all of the following:
- Foreign organs: matter coming from the source plant but not defined as the herbal drug;
- Foreign elements: matter not coming from the source plant and of either vegetable or mineral origin;
- Other foreign elements: matter such as moulds and animal contamination (e. g. insects, their eggs or larvae, spiders, rodents and excreta) and any other unwanted matter (e. g. glass, metal, plastics).
Furthermore, it has been clarified that the quantitative limits for foreign matter that are specified in general Ph. Eur. monographs (e. g. Herbal drugs, max. 2 %) or in an individual monograph, only apply to foreign organs and foreign elements; other foreign elements as defined in 2.8.2 are not covered by the limit but should, as far as possible, be absent.
Related GMP News
29.09.2026FDA wants to Advance the Development of Herbal Medicinal Products
29.09.2026Ph. Eur. Draft for Comment: 2.8.18. Determination of Aflatoxin B1 in Herbal Drugs
29.09.2026Can Cannabis Flowers be pre-dried in Accordance with GACP?
29.09.2026Water Determination in Herbal Drugs
10.09.2026New Information Sheet regarding Cannabis for Medical Purposes
10.09.2026EMA Reflection Paper on Safety Signals for Herbal Medicinal Products


